Document Detail

Cardioverter-defibrillators: a cost or an investment?
MedLine Citation:
PMID:  21518745     Owner:  NLM     Status:  In-Process    
Implantable cardioverter-defibrillator (ICD) therapy has emerged as the most effective treatment for life-threatening ventricular arrhythmias. Most studies indicate that ICD therapy in appropriately selected patients at high risk of sudden cardiac death (SCD) is associated with cost-effectiveness ratios similar to, or better than, other accepted treatments, including renal dialysis. The up-front costs of ICD therapy are admittedly high and as such, ICD implantation is more akin to an operation than a drug. As would be the case for a life-saving operation, the adoption of short time horizons is apt to lead to underestimations of cost effectiveness. As well as the time horizon, the underlying aetiology of the arrhythmic substrate, implantation technique, ICD battery life, and the presence of co-morbidities are important issues in maximizing cost effectiveness. Above all, we should consider that ICD therapy is the only available option for prolonging survival in patients who are at risk of SCD.
Francisco Leyva; Ignacio Fernandez Lozano; John Morgan
Related Documents :
15890575 - A permanent breast seed implant as partial breast radiation therapy for early-stage pat...
6099405 - Intracerebral neutron brachytherapy for hemispheric glioblastoma multiforme. a pilot st...
23228265 - Comparative evaluation of fracture resistance under static and fatigue loading of endod...
8567095 - Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy...
8248715 - Development of an animal model for testing human breast implantation materials.
6630405 - The relative efficiencies of matched and independent sample designs for case-control st...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology     Volume:  13 Suppl 2     ISSN:  1532-2092     ISO Abbreviation:  Europace     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883649     Medline TA:  Europace     Country:  England    
Other Details:
Languages:  eng     Pagination:  ii25-31     Citation Subset:  IM    
Centre for Cardiovascular Sciences, Queen Elizabeth Hospital, University of Birmingham, Birmingham B15 2TH, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Patient associations as stakeholders: a valuable partner for facilitating access to therapy.
Next Document:  Economic evaluation in cardiology.